Search

everythinglearnresearchcommunity

for

Search:↓

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Tailor treatments for vitiligo to patient needs for best results.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Skin treatment can lower life quality for patients with skin conditions.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Terbinafine can cause hair loss.

Ayurvedic treatment effectively cured a boy's alopecia areata with no side effects or recurrence.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.